2022 Myofilament Meeting

Byctmr1

In May, CTMR Investigators participated in the 2022 Myofilament research conference “Myofilament Form and Function: Determinants of Sarcomeric Contractility” in Madison, Wisconsin.

Saffie Mohran presented “Embryonic myosin mutations T178I & R672C result in mechanical and structural dysfunction in hPSC derived skeletal muscle”.
Farid Mousseri-Harami presented “Dancamtiv reversed negative effects on cardiac myofilament function in the I61Q cTnC mouse model of dilated cardiomyopathy”.

Similar Posts

Farid Moussavi-Harami

CTMR Pilot Grant Recipient Dr. Farid Moussavi-Harami awarded NIH R01 Grant

Byctmr1

A huge congratulations to 2020 CTMR pilot grant recipient Farid Moussavi-Harami, MD, who recently received a Notice of Award for his first NIH R01 grant! An Assistant Professor with the UW Medicine’s Division of Cardiology, Dr. Moussavi Harami’s CTMR pilot grant study focused on the genetic mutations, such as dilated cardiomyopathy, impacted contractile force in…

Dr. Ru Gunawardane joins CTMR External Advisory Board

Dr. Ru Gunawardane joins CTMR External Advisory Board

Byctmr1

We are excited to announce that Ruwanthi (Ru) Gunawardane, Ph.D. is joining CTMR as a member of our External Advisory Board. Ru was recently named Executive Director of the Allen Institute for Cell Science in 2020 after spending five years at Amgen, where she worked on assay development for multiple drug targets spanning oncology, inflammation,…